Linde sells €1.4bn of revenue and €305m of EBITDA

16/07/18 -"€2.7bn of revenue and €700m of EBITDA have been sold to convince the anti-trust authorities that a merged Linde/Praxair will not have a dominant position in one or other region. It is possible that ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

16/07/18

Download

You may also be interested by these reports :

26/04/24

Yara International

Investors sold off the stock after Yara’s Q1 release as the results came in well short of the consensus (sales: -14.5%; adjusted EBTDA: -14.5%). This ...

26/04/24

Symrise

Will the new management deliver on the margin recovery?

25/04/24

BASF SE

Strong start, but cautious outlook on 2Q24E as 1Q was influenced by restocking

25/04/24

Symrise

Similar trends as at Givaudan: String 1Q, volume-driven but boosted by FX-pricing in LatAm plus Fragrance as key category contributor

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue

Linde plc